Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant

Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.

Abstract

Supplemental Digital Content is available in the text.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Antibodies, Viral / immunology
  • BNT162 Vaccine
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / immunology
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Humans
  • Immunity, Cellular / drug effects*
  • Immunity, Humoral / drug effects*
  • Immunization, Secondary / statistics & numerical data*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Kidney Transplantation / adverse effects
  • Male
  • Middle Aged
  • SARS-CoV-2 / immunology
  • Transplant Recipients / statistics & numerical data*

Substances

  • Antibodies, Viral
  • COVID-19 Vaccines
  • Immunosuppressive Agents
  • BNT162 Vaccine